Emily Pulford
Bedford Park, SA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature.
Journal: Pathology
Published: November 08, 2023
Malignant mesothelioma in situ: diagnostic and clinical considerations.
Journal: Pathology
Published: January 23, 2020
Pleural malignant mesothelioma versus pleuropulmonary synovial sarcoma: a clinicopathological study of 22 cases with molecular analysis and survival data.
Journal: Pathology
Published: April 17, 2018
Quantitative mass spectrometry to identify protein markers for diagnosis of malignant pleural mesothelioma.
Journal: Journal of proteomics
Published: April 09, 2018
The Effect of Aquaporin 1-Inhibition on Vasculogenic Mimicry in Malignant Mesothelioma.
Journal: International journal of molecular sciences
Published: September 29, 2017
Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?
Journal: Disease markers
Published: May 17, 2017
Vasculogenic mimicry in vitro in tumour cells derived from metastatic malignant pleural effusions.
Journal: Pathology
Published: February 08, 2017
Usefulness of Aquaporin 1 as a Prognostic Marker in a Prospective Cohort of Malignant Mesotheliomas.
Usefulness of Aquaporin 1 as a Prognostic Marker in a Prospective Cohort of Malignant Mesotheliomas.
Journal: International journal of molecular sciences
Published: May 25, 2016
Vasculogenic mimicry in malignant mesothelioma: an experimental and immunohistochemical analysis.
Journal: Pathology
Published: May 06, 2016
Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.
Journal: British journal of cancer
Published: March 25, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026